Therapy Optimization Trial for the Treatment of Relapsed or Refractory Brain Tumors in Children

NCT00749723 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

174

Enrollment

OTHER

Sponsor class

Conditions

Recurrent Brain Tumors
Supratentorial PNETs
Medulloblastomas
Ependymomas

Interventions

DRUG: carboplatin
DRUG: etoposide
DRUG: temozolomide
DRUG: thiotepa, carboplatin, etoposide
DRUG: temozolomide, thiotepa
PROCEDURE: autologous stem cell transplantation
DRUG: intraventricular etoposide
DRUG: trofosfamide, etoposide

Sponsor

University Hospital, Bonn